Lv52
1570 积分 2023-09-09 加入
Bile Acid Signaling in Metabolic and Inflammatory Diseases and Drug Development
2天前
已完结
Engineered Therapeutic Bacteria with High-Yield Membrane Vesicle Production Inspired by Eukaryotic Membrane Curvature for Treating Inflammatory Bowel Disease
1个月前
已完结
Oral delivery of berberine by liver-targeted zwitterionic nanoparticles to overcome multi-intestinal barriers and extend insulin treatment duration
2个月前
已完结
Altered microbial bile acid metabolism exacerbates T cell-driven inflammation during graft-versus-host disease
2个月前
已完结
Bile acid synthesis impedes tumor-specific T cell responses during liver cancer
2个月前
已完结
Materials modulate immunity and gut microbiome
2个月前
已完结
High-pressure homogenization and tailoring of size-tunable Ganoderma lucidum spore oil nanosystem for enhanced anticancer therapy
2个月前
已完结
Ursodeoxycholic acid in cholestatic liver disease: Mechanisms of action and therapeutic use revisited
2个月前
已完结
α4β7 integrin inhibitors: a patent review
2个月前
已完结
Primary sclerosing cholangitis (PSC) and inflammatory bowel disease (IBD): a condition exemplifying the crosstalk of the gut–liver axis
3个月前
已完结
皖公网安备34019202002308
